Fidelity Disruptive Medicine ETF
FMED
NASDAQ
Weiss Ratings | FMED - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Weak | |||
Reward Grade | D+ | |||
Risk Index | Weak | |||
Risk Grade | D+ | |||
Valuation | FMED - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Price | $23.57 | |||
Company Info | FMED - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | Fidelity Investments | |||
Manager/Tenure (Years) | Camille L Carlstrom (5), Timothy E Codrington (5), Charlie W Hebard (5), 3 others | |||
Website | http://www.institutional.fidelity.com | |||
Phone Number | 617-563-7000 | |||
Fund Information | FMED - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | Fidelity Disruptive Medicine ETF | |||
Category | Health | |||
Sub-Category | Healthcare Sector Equity | |||
Prospectus Objective | Specialty - Health | |||
Inception Date | Apr 16, 2020 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | -- | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | FMED - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 0.47% | |||
Dividend | FMED - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 0.23% | |||
Asset Allocation | FMED - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 8.18% | |||
Stock | 99.63% | |||
U.S. Stock | 88.81% | |||
Non-U.S. Stock | 10.82% | |||
Bond | 0.00% | |||
U.S. Bond | 0.00% | |||
Non-U.S. Bond | 0.00% | |||
Preferred | 0.00% | |||
Convertible | 0.00% | |||
Other Net | -7.81% | |||
Price History | FMED - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -2.40% | |||
30-Day Total Return | -1.52% | |||
60-Day Total Return | 0.17% | |||
90-Day Total Return | -3.11% | |||
Year to Date Total Return | -4.56% | |||
1-Year Total Return | -4.73% | |||
2-Year Total Return | -4.21% | |||
3-Year Total Return | -1.72% | |||
5-Year Total Return | -7.15% | |||
Price | FMED - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | $23.57 | |||
1-Month Low Price | $23.49 | |||
1-Month High Price | $24.22 | |||
52-Week Low Price | $21.43 | |||
52-Week Low Price (Date) | Apr 08, 2025 | |||
52-Week High Price | $26.61 | |||
52-Week High Price (Date) | Jan 30, 2025 | |||
NAV | FMED - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
1-Month Low NAV | $23.49 | |||
1-Month High NAV | $24.20 | |||
52-Week Low NAV | $21.52 | |||
52-Week Low NAV (Date) | Apr 08, 2025 | |||
52-Week High NAV | $26.64 | |||
52-Week High Price (Date) | Jan 30, 2025 | |||
Beta / Standard Deviation | FMED - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.94 | |||
Standard Deviation | 17.25 | |||
Balance Sheet | FMED - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 53.39M | |||
Operating Ratios | FMED - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 0.50% | |||
Turnover Ratio | 30.00% | |||
Performance | FMED - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 9.76% | |||
Last Bear Market Total Return | -16.20% | |||